Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Dermatology
•
Drug Eruptions
How do you approach monitoring in DRESS or DiHS patients?
Which tests do you order and when do you re-order tests?
Related Questions
In difficult cases, what is your approach to find a causative agent of fixed drug or fixed food eruption?
After corticosteroids, what second line agent do you select to treat drug induced hypersensitivity syndrome (also known as DRESS syndrome)?
Would you give lung SBRT to a patient with bullous pemphigoid on the chest and torso?
How frequently do you recommend skin cancer screens in your patients with kidney transplants who are on immunosuppression?
Are there certain disease domains in a patient with psoriatic arthritis that will make bimekizumab a particularly good option?
How do you dose oral tranexamic acid for melasma?
How often do you check desmoglien antibodies in pemphigus patients after treatment and during remission?
What is your treatment approach to non-uremic calciphylaxis? Which treatment modalities do you combine?
How do you approach treatment escalation to systemic agents for erythromelalgia, after treating with topicals and trigger avoidance?
How does trimethoprim-sulfamethoxazole's efficacy against S. pyogenes influence your empirical treatment of skin infections in regions with high resistance rates?
